Validation of 46-gene CCP RNA Signature for Predicting PCa Death

Validation of a 46-gene Cell Cycle Progression (CCP) RNA Signature for Predicting Prostate Cancer Death

Peter T. Scardino, MD, FACS
Memorial Sloan Kettering Cancer Center

Click HERE to read an exclusive report by a UroToday medical writer.

Click HERE to view the poster from this session.

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe